Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Cost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Arcadia Biosciences (RKDA) Profit After Tax (2016 - 2025)

Historic Profit After Tax for Arcadia Biosciences (RKDA) over the last 12 years, with Q3 2025 value amounting to $856000.0.

  • Arcadia Biosciences' Profit After Tax rose 15310.17% to $856000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$5.1 million, marking a year-over-year decrease of 29.69%. This contributed to the annual value of -$7.0 million for FY2024, which is 4972.86% up from last year.
  • As of Q3 2025, Arcadia Biosciences' Profit After Tax stood at $856000.0, which was up 15310.17% from -$4.5 million recorded in Q2 2025.
  • Over the past 5 years, Arcadia Biosciences' Profit After Tax peaked at $3.2 million during Q2 2023, and registered a low of -$9.6 million during Q4 2021.
  • Over the past 5 years, Arcadia Biosciences' median Profit After Tax value was -$2.9 million (recorded in 2023), while the average stood at -$2.6 million.
  • Examining YoY changes over the last 5 years, Arcadia Biosciences' Profit After Tax showed a top increase of 20726.37% in 2025 and a maximum decrease of 34097.3% in 2025.
  • Quarter analysis of 5 years shows Arcadia Biosciences' Profit After Tax stood at -$9.6 million in 2021, then skyrocketed by 54.71% to -$4.3 million in 2022, then surged by 33.76% to -$2.9 million in 2023, then tumbled by 41.75% to -$4.1 million in 2024, then skyrocketed by 121.06% to $856000.0 in 2025.
  • Its Profit After Tax was $856000.0 in Q3 2025, compared to -$4.5 million in Q2 2025 and $2.6 million in Q1 2025.